RIGI and cancer: Together, these data suggest that the bi‐functional 3p‐125b‐ASO comprises two distinct and independent functions, which can simultaneously inhibit oncogenic miR‐125b and activate RIG‐I signalling, leading to immunogenic death of cancer cells.